SiftrBio Analysis: $1M Raised
What is SiftrBio?
Next-generation ADC development platform
Product Features & Capabilities
- SIFTR platform for ADC linker development
- High throughput linker design
- Human tissue-based linker optimization
Use Cases
Develop new ADCs for hard-to-treat cancers; Improve efficacy of existing ADCs; Reduce side effects in cancer treatments; Utilize human tumor tissue for linker design; Drive high throughput development of ADC linkers
Other Considerations
Received £1 million investment for ADC development; Awarded £827K grant from EPSRC for ADC linker research; Backed by Imperial College and Cancer Research Horizons
See something that needs updating? Suggest edits to this profile.